Hoang-Minh, Lan B.
Mitchell, Duane A.
Article History
First Online: 11 October 2018
Compliance with Ethical Standards
:
: Lan B. Hoang-Minh declares that she has no conflict of interest.Duane A. Mitchell holds patented technologies that have been licensed or have exclusive options to license to Celldex Therapeutics, Annias, Immunomic Therapeutics, and iOncologi; receives research funding from Immunomic Therapeutics; serves as an advisor/consultant to Bristol-Myers Squibb, Tocagen, and Oncorus; and is co-founder of iOncologi, Inc., an immuno-oncology biotechnology company.
: This article does not contain any studies with human or animal subjects performed by any of the authors.